| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39bf0bb8b07e151d4bcead749d7dd699 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-045 |
| filingDate |
2011-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a0fbac44c2f133ac5e1c1d763486ea3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ce8db39dfea96394c75dd10030ff901
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff8143b7f3a76a8e73d4373d5851f634 |
| publicationDate |
2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112013008624-A2 |
| titleOfInvention |
cytomegalovirus gb (cmv) polypeptide, preparation, immunogenic composition, polynucleotide, recombinant vector, host cell, use of cmv gb polypeptide, and, methods for producing an immune response against cmv and for preventing congenital infection against cmv in a newborn |
| abstract |
Cytomegalovirus gb polypeptide (cmv), preparation, immunogenic composition, polynucleotide, recombinant vector, and host cell The invention relates to a cytomegalovirus gb polypeptide (cmv) comprising at least a portion of a gb protein extracellular domain comprising a fusion loop 1 (fl1) and a fusion loop 2 domain (fl2), at least one of the fl1 and fl2 domains comprising at least one amino acid deletion or substitution. |
| priorityDate |
2010-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |